SOUTHWELL DAVID P

The estimated net worth of SOUTHWELL DAVID P is at least $2 Million dollars as of 07/06/2022. SOUTHWELL DAVID P is the Director of Rocket Pharmaceuticals Inc. SOUTHWELL DAVID P owns over 95,160 shares of Rocket Pharmaceuticals Inc stock worth over $1 Million . SOUTHWELL DAVID P is the Director of PTC Therapeutics Inc. SOUTHWELL DAVID P owns over 1,650 shares of PTC Therapeutics Inc stock worth over $70,735.50. SOUTHWELL DAVID P is the Director of First Eagle Alternative Capital BDC Inc. SOUTHWELL DAVID P owns over 38,500 shares of First Eagle Alternative Capital BDC Inc stock worth over $125,895.00. SOUTHWELL DAVID P is the CEO of TScan Therapeutics Inc. SOUTHWELL DAVID P owns over 171,569 shares of TScan Therapeutics Inc stock worth over $555,883.56.

SOUTHWELL DAVID P mailing address: C/O INOTEK PHARMACEUTICALS CORPORATION 91 HARTWELL AVENUE LEXINGTON MA 02421

Insider Roles

Name Transaction Date Position
PTC Therapeutics Inc 2017-01-03 director
Rocket Pharmaceuticals Inc 2016-03-22 director, officer: See Remarks
Spero Therapeutics Inc 2018-02-01 director
First Eagle Alternative Capital BDC Inc 2010-11-16 director
TScan Therapeutics Inc 2021-07-15 director, officer: Chief Executive Officer
EMBED
SAVE

SOUTHWELL DAVID P trading performance

Average Relative Return

6.03%

Average relative return per transaction

Outperforming Transactions

33%

2 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .

SOUTHWELL DAVID P trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) 1.7 3.55 1.37 6.03 30.98 61.37
Relative Return to S&P 500(%) -2.92 -5.34 -8.83 2.47 14.7 12.51

Southwell David P trading transactions

Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Filing Date Dividend Yield % PE Ratio Market Cap ($M)
TCRX
TScan Therapeutics Inc
$3.24
SOUTHWELL DAVID P
CEO
2022-05-18 Buy
25,000
17.06%
$3.59
$89,750
171,569
-9.75%
2022-05-20
0
At Loss
77.86
TCRX
TScan Therapeutics Inc
$3.24
SOUTHWELL DAVID P
CEO
2021-09-08 Buy
11,000
12.66%
$8.73
$96,030
97,899
-62.89%
-
0
At Loss
77.86
PTCT
PTC Therapeutics Inc
$42.97
SOUTHWELL DAVID P
Director
2020-10-16 Sell
27,000
-94.24%
$51.54
$1,391,580
1,650
-16.63%
-
0
At Loss
3,058.27
RCKT
Rocket Pharmaceuticals Inc
$15.82
SOUTHWELL DAVID P
Director
2018-12-13 Sell
38,768
-28.95%
$15.19
$588,886
95,160
4.15%
-
0
At Loss
1,035.63
RCKT
Rocket Pharmaceuticals Inc
$15.82
SOUTHWELL DAVID P
Director
2018-12-07 Sell
57,732
-30.12%
$15.13
$873,485
133,928
4.56%
-
0
At Loss
1,035.63
RCKT
Rocket Pharmaceuticals Inc
$15.82
SOUTHWELL DAVID P
President and CEO
2017-01-06 Buy
60,000
2,169.98%
$1.75
$105,000
15,691.25
804%
-
0
At Loss
1,035.63
PTCT
PTC Therapeutics Inc
$42.97
SOUTHWELL DAVID P
Director
2015-07-06 Sell
23,604
-100%
$47.52
$1,121,660
0
-9.57%
-
0
At Loss
3,058.27
PTCT
PTC Therapeutics Inc
$42.97
SOUTHWELL DAVID P
Director
2015-03-23 Sell
2,317
-21.22%
$69.04
$159,966
8,604
-37.76%
-
0
At Loss
3,058.27
PTCT
PTC Therapeutics Inc
$42.97
SOUTHWELL DAVID P
Director
2014-03-21 Sell
2,317
-17.50%
$30.93
$71,664.80
10,921
38.93%
-
0
At Loss
3,058.27
FCRD
First Eagle Alternative Capital BDC Inc
$3.27
SOUTHWELL DAVID P
Director
2010-12-06 Buy
12,100
45.83%
$13
$157,300
38,500
-74.85%
-
12.23
21.80
97.84
FCRD
First Eagle Alternative Capital BDC Inc
$3.27
SOUTHWELL DAVID P
Director
2010-11-19 Buy
11,899
84.39%
$12.84
$152,783
25,999
-74.53%
-
12.23
21.80
97.84
FCRD
First Eagle Alternative Capital BDC Inc
$3.27
SOUTHWELL DAVID P
Director
2010-11-17 Buy
14,100
100%
$12.84
$181,044
14,100
-74.53%
-
12.23
21.80
97.84
Total 12
  • 1

SOUTHWELL DAVID P personal network

Name Position Linked company